Cite
HARVARD Citation
Akaev, I. et al. (n.d.). 270 Large single-site institution experience of testing for somatic and germline concordance BRCA1/2 pathogenic mutations in ovarian cancer patients eligible for PARP inhibitors therapy. International journal of gynecological cancer. p. A114. [Online].